In keeping with the global loss of 5hmC in GSCs, SREBF2 expression is also downregulated in GSCs compared with NSCs and, along with ZIC3, is related to poorer survival as analyzed using GBM data from TCGA (Fig. 5b, Additional file 1: Table S6). The gene discussed is SREBF2; the disease is glioblastoma.